Product
ACD856
1 clinical trial
2 indications
Indication
Cognitive DisorderIndication
Alzheimer's diseaseClinical trial
A Phase 0, Open-label, Non-controlled Study to Evaluate the Pharmacokinetics of a Single Intravenous Microdose of ACD856 in Healthy VolunteersStatus: Completed, Estimated PCD: 2020-04-18